Trial · NCT04124614
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo Run-in Period | STARTED | Placebo | 450 | |
| Placebo Run-in Period | STARTED | Brexpiprazole + Sertraline | 0 | |
| Placebo Run-in Period | STARTED | Sertraline + Placebo | 0 | |
| Placebo Run-in Period | COMPLETED | Placebo | 416 | |
| Placebo Run-in Period | COMPLETED | Brexpiprazole + Sertraline | 0 | |
| Placebo Run-in Period | COMPLETED | Sertraline + Placebo | 0 | |
| Placebo Run-in Period | NOT COMPLETED | Placebo | 34 | |
| Placebo Run-in Period | NOT COMPLETED | Brexpiprazole + Sertraline | 0 | |
| Placebo Run-in Period | NOT COMPLETED | Sertraline + Placebo | 0 | |
| Double Blind Treatment Period | STARTED | Placebo | 0 | |
| Double Blind Treatment Period | STARTED | Brexpiprazole + Sertraline | 214 | |
| Double Blind Treatment Period | STARTED | Sertraline + Placebo | 202 | |
| Double Blind Treatment Period | Randomized Sample | Placebo | 0 | |
| Double Blind Treatment Period | Randomized Sample | Brexpiprazole + Sertraline | 214 | |
| Double Blind Treatment Period | Randomized Sample | Sertraline + Placebo | 202 | |
| Double Blind Treatment Period | Enriched Randomized Sample | Placebo | 0 | |
| Double Blind Treatment Period | Enriched Randomized Sample | Brexpiprazole + Sertraline | 160 | |
| Double Blind Treatment Period | Enriched Randomized Sample | Sertraline + Placebo | 150 | |
| Double Blind Treatment Period | FAS Enriched Sample | Placebo | 0 | |
| Double Blind Treatment Period | FAS Enriched Sample | Brexpiprazole + Sertraline | 149 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04124614/flow